Connect with us

Technology

Fresh Coat Painters Empowers Franchisees With Unmatched Support and Community

Published

1 year ago

on

The national painting franchise offers a robust support system, including operational guidance, ongoing support, and specialized communication channels and educational platforms.

CINCINNATI, May 20, 2025 /PRNewswire-PRWeb/ — For aspiring entrepreneurs, the decision to invest in a franchise often hinges on the support system provided by the franchisor. Fresh Coat Painters, a national painting franchise, stands out with its comprehensive and multifaceted approach to franchisee support, fostering a collaborative environment where business owners can thrive.

“Many people can open a business on their own,” said Jeffrey Deraway, vice president of operations and education. “But having the unique support of a franchisor and a franchise community is what makes Fresh Coat stand out. Currently, we have a combined hundreds of years of experience just on our leadership team, and franchisees get to lean on.”

Fresh Coat cultivates a strong sense of community among its franchisees, encouraging them to share their experiences, knowledge and challenges.

This collaborative spirit provides a safety net for new business owners who might otherwise face the uncertainties of entrepreneurship alone.

“Think of it as community support,” Deraway said. “You can go, you can get answers, you can get different ways to think about it.”

Comprehensive Resources and Tools
The support system begins well before launch, with a structured pre-launch process using a tool called Process Street. This step-by-step guide ensures franchisees meet critical milestones and are well-prepared for training.

Fresh Coat Academy, an online learning platform, provides a wealth of resources at franchisees’ fingertips.
“There are thousands of resources available, from articles and business forms to videos,” Deraway said. “I recently created about 50 videos on using our primary software, and it reinforced just how essential repetition is for mastery. We prioritize accessible learning, and providing this resource ensures our franchisees can practice and refine their skills anytime, anywhere.”

Personalized Coaching and Mentorship
Franchisees are not left to navigate the challenges of business ownership alone. They are assigned coaches who provide guidance and support through weekly calls and monthly milestones.

“As soon as a franchisee joins, they’re paired with a dedicated coach,” Deraway said. “First, they work with a ‘get-to-training’ coach who guides them through Process Street, assists with administrative tasks, and helps them access key resources. After training, they transition to an onboarding coach who supports them for three to six months, holding weekly calls to track launch progress or explore growth opportunities for those already in business. The journey continues with a Business Coach that works with you bi-weekly to continue to help you scale your business, grow your revenue and prioritize your profitability.”

This personalized approach ensures franchisees stay on track and have access to expert advice.

Open Communication and Collaboration
Fresh Coat fosters a culture of open communication and collaboration among its franchisees. Through group meetings and a dedicated platform called The Circle, franchisees can connect, share experiences, and seek advice from peers.

“We have multiple channels for communication,” Deraway said. “The Circle allows franchisees to ask questions, seek advice, and discuss challenges. Owners from across the country, with varying levels of experience, can share insights and offer solutions.”

Additionally, Fresh Coat’s Franchise Advisory Committee provides franchisees with a voice in shaping the system’s future. This collaborative approach ensures the franchisor remains responsive to the needs and concerns of its owners.

Beyond the Basics: Commercial Support and Strategic Partnerships
Fresh Coat’s support extends beyond the typical areas of marketing, operations and technology. A dedicated commercial department focuses on securing national accounts, providing franchisees with access to lucrative commercial painting projects.

The company also boasts a strategic partnership with Sherwin-Williams, offering franchisees access to advanced training, technical support and resources at the local level. This relationship not only enhances their professional development but also helps franchisees establish themselves in their local markets.

Continuous Learning and Development
Recognizing that learning is an ongoing process, Fresh Coat provides continuous training and development opportunities. Site Visits, webinars and a national convention keep franchisees up-to-date on industry trends and best practices.

The comprehensive support system at Fresh Coat is more than just a collection of resources; it’s a strategic framework designed to empower franchisees to build thriving businesses. By providing access to tools, training, a supportive community and ongoing development opportunities, Fresh Coat helps franchisees navigate the complexities of business ownership and achieve their goals.

To find out more information on costs to buy this franchise, please visit https://1851franchise.com/freshcoat/info.

Media Contact

Jessica Tcholakov, Fresh Coat Painters, 224-436-1005, freshcoatpr@freshcoatpainters.com, https://freshcoatpainters.com/

View original content:https://www.prweb.com/releases/fresh-coat-painters-empowers-franchisees-with-unmatched-support-and-community-302460783.html

SOURCE Fresh Coat Painters

Related Topics:
Continue Reading

Technology

HiTHIUM Partners with the University of Cambridge to Advance International Industry-Academia Collaboration in Long-Duration Energy Storage

Published

17 minutes ago

on

November 14, 2026

By

XIAMEN, China, Nov. 14, 2026 /PRNewswire/ — On November 12, the Global Energy Storage Colloquium was held in Xiamen. During the colloquium, HiTHIUM and the University of Cambridge signed a memorandum of understanding (MoU), establishing a strategic partnership. The two parties will collaborate on frontier scientific research, key technology innovation and industrial applications in battery energy storage, bringing academic research into closer alignment with industry needs and exploring new models for international industry-academia collaboration. The partnership aims to contribute to the advancement of global energy storage technology and the industry.

The UK has a strong track record in the development of modern battery technologies and fundamental research. The University of Cambridge is one of the world’s leading universities, with internationally recognized expertise in engineering, materials science and fundamental research. As a leading global energy storage technology company, HiTHIUM has long focused on energy storage technology development and commercialization. It continues to advance integrated research and innovation across the value chain, from high-capacity energy storage cells to long-duration energy storage systems and grid integration technologies.

The collaboration is intended to bring internationally leading academic research into closer engagement with innovation across China’s energy storage industry. The University of Cambridge’s strengths in fundamental science, materials research and engineering will offer new perspectives and approaches to key scientific questions and emerging technologies in energy storage. HiTHIUM will bring its experience in long-duration energy storage (LDES), product development and large-scale deployment, connecting research with real industry needs and application scenarios, and supporting the engineering validation and commercialization of research outcomes. By drawing on the strengths of both research and industry, the partnership will strengthen the links between frontier innovation and practical applications.

Under the cooperation plan, the two parties will establish joint management and research collaboration mechanisms, bringing together academic resources and corporate R&D capabilities. They will work together to plan research projects, facilitate scientific exchange and support the translation of research outcomes, strengthening connections between fundamental research, technology development and industrial applications so that innovation in energy storage can better serve industry needs.

The partnership also marks an important step in HiTHIUM’s efforts to expand its international innovation network. Building on this collaboration with the University of Cambridge, HiTHIUM will further strengthen academic exchanges and research partnerships with leading universities and research institutions around the world. By bringing together international research resources and talent, the company aims to encourage collaboration across disciplines and technology fields, explore the development of technologies such as LDES from a global perspective, and bring technical challenges and application needs from the front lines of industry into research and innovation. This will help research and industrial practice reinforce one another.

View original content to download multimedia:https://www.prnewswire.com/news-releases/hithium-partners-with-the-university-of-cambridge-to-advance-international-industry-academia-collaboration-in-long-duration-energy-storage-302939492.html

SOURCE HiTHIUM

Continue Reading

Technology

The NYSE Welcomes vVARDIS as a Publicly Listed Company

Published

1 hour ago

on

November 14, 2026

By

NEW YORK, Nov. 14, 2026 /PRNewswire/ — vVARDIS (NYSE: VVVV) co-founders Dr. Haley Abivardi and Dr. Goly Abivardi aim to reshape the future of dental care with a drill-free treatment for the world’s #1 non-communicable disease: cavities.

vVARDIS Solves a Problem that Millions FaceTooth decay affects billions of people worldwide, and dental anxiety keeps millions from getting the care they need.vVARDIS is a Swiss dental technology company focused on changing the way early tooth decay is treated.vVARDIS has introduced a new approach that aims to treat decay earlier and more comfortably for patients.Its flagship product, Curodont® Repair Fluoride Plus, uses proprietary peptide technology to help repair early-stage tooth decay by supporting the natural remineralization of enamel — simply put No drill, No needle, or No filling.Tooth Decay is One of the Most Common Health Issues in the World2.5 billion people globally live with untreated tooth decay.Nearly 90% of U.S. adults have experienced tooth decay.Nearly 73% of U.S. adults report dental fear.21% avoid the dentist because of anxiety.The Story that Helped Shape vVARDISFor decades, treating early tooth decay often meant waiting until it worsened or getting a filling. The founders spent 25 years developing Curodont® Repair Fluoride Plus, a treatment that helps repair early tooth decay before it becomes a cavity.Curodont® gives dentists a way to treat early decay while making the experience easier and less intimidating for patients.The technology has already treated more than 2.5 million teethAvailable in more than 20% of U.S. dental practices

Click Here to Learn More about vVARDIS: https://www.youtube.com/watch?v=T1p9hUR5Glk

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/the-nyse-welcomes-vvardis-as-a-publicly-listed-company-302939487.html

SOURCE New York Stock Exchange

Continue Reading

Technology

Innovative Immunology Biotech Windward Bio Lists on Nasdaq

Published

4 hours ago

on

November 14, 2026

By

SHANGHAI, Nov. 14, 2026 /PRNewswire/ — Windward Bio, a portfolio company of Qiming Venture Partners and a clinical-stage biotechnology company, successfully listed on Nasdaq on November 13, 2026. Windward Bio (Nasdaq: WWB) priced its IPO at $17.00 per share. Its shares closed at $28.50 on the first trading day, up 68% from the IPO price, giving the company a market capitalization of approximately $1.69 billion. This is Qiming Venture Partners’ 11th IPO in 2026.

Qiming Venture Partners invested in Windward Bio’s inaugural Series A financing in 2025 and continued to support the company in its Series B financing in 2026. Qiming also participated in this IPO financing round.

Windward Bio was founded in 2024 with a mission to transform the treatment paradigm for patients living with chronic inflammatory diseases through the development of differentiated biologic therapies targeting clinically validated disease pathways. Led by a team with extensive expertise across discovery, development, and commercialization, Windward Bio is advancing a pipeline of ultra-long-acting antibody medicines to improve clinical outcomes, reduce treatment burden and expand treatment options for patients with serious respiratory and dermatologic diseases, including asthma, chronic obstructive pulmonary disease (COPD) and atopic dermatitis.

Windward Bio’s lead program, WIN378, is a potentially novel anti-TSLP monoclonal antibody engineered for improved potency and extended half-life. WIN378 is currently being evaluated in POLARIS-1, a Phase 2/3 study in severe uncontrolled asthma, and SIRIUS, a Phase 2 study in COPD. The company’s pipeline also includes WIN027, a clinical-stage, long-acting bispecific antibody targeting TSLP and IL-13 with potential applications across multiple inflammatory and immunological diseases. Windward Bio holds exclusive global rights (excluding Greater China and certain Asian countries) to WIN378 through a licensing agreement with Kelun-Biotech and Harbour BioMed, and has separately licensed WIN027 from Qyuns Therapeutics.

“Qiming Venture Partners invests in differentiated, globally competitive biotech innovation designed to address significant unmet needs for patients, and Windward Bio exemplifies this approach. We believe novel, long-acting biologics will reshape the treatment of severe chronic respiratory and skin diseases, and that WIN378 and WIN027 have the potential to expand and meaningfully improve the treatment options available to patients. In the hands of Luca and his team, with their expertise and proven track record, Windward is well-positioned to deliver on this potential, and we look forward to supporting the company through its next phase of growth,” said Alexander Sinclair Wilson, Principal at Qiming Venture Partners.

About Qiming Venture Partners

Qiming Venture Partners was founded in 2006. Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companies in the Technology and Healthcare industries at the early and growth stages.

Since our debut, we have backed over 630 fast-growing and innovative companies. Over 290 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 110 portfolio companies that have achieved unicorn or super unicorn status.

Many of our portfolio companies are today’s most influential firms in their respective sectors, including Xiaomi, Meituan, Bilibili, Zhihu, Roborock, Hesai Technology, UBTech, WeRide, HyperStrong, Insta360, Unisound, Biren Technology, Z.AI, Gan & Lee Pharmaceuticals, Tigermed, Zai Lab, CanSino Biologics, Schrödinger, APT Medical, Sanyou Medical, AmoyDx, SinocellTech, Insilico Medicine, AusperBio, Yuanxin Technology, Medilink Therapeutics, LaNova Medicines, StepFun, among many others.

 

View original content:https://www.prnewswire.com/news-releases/innovative-immunology-biotech-windward-bio-lists-on-nasdaq-302939481.html

SOURCE Qiming Venture Partners

Continue Reading

Trending